ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[NFKBIA]
GO:1901222;regulation of NIK/NF-kappaB signaling;7.0;0.8436909121759173;0.7727648213451592;9.34084218004034;45.070113835906206;5.223196736079928;0.001508456149618737;0.6180338892438164;[NFKBIA, NLRP12, IL23A, PRDX1, SPHK1, BCL3, ZFP91, NLRP3, LIMS1]
GO:1905146;lysosomal protein catabolic process;8.0;1.0;0.875;9.628524252492122;325.4145966205827;8.67846133901236;0.010891333694767644;0.8188169164668168;[LAMP2]
GO:0060800;regulation of cell differentiation involved in embryonic placenta development;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;69.44287305328919;8.390779266560578;0.0023241904665653296;0.7522251544931926;[STK3]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[NLRP12, NLRP3]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[PBX3, NTSR1, PAFAH1B1, ARCN1]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, UBE2I, BUD31, SPHK1, ITGB2, CIB1, NLRC4, TMEM173, LRP8, STK3, COPS5, EP300, TRIM14, NLRP3, ARHGEF5]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, TRIM14, NLRP3, CIB1, NLRC4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[CDKN1C, USP36, CIITA, BTG2, NAB1, GFI1, GMNN, ARID4A, OTUD7B, IKZF2, YY1, FLCN, NIPBL, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, LRRFIP1, ZNF564, DACT1, TLE4, ZNF485, TSC22D4, PEG3, ZNF282, RUNX2, SIRT2, EID1, ILF3, SFRP1, ZNF93, TFDP2, MTF2, HOXB4, TIMELESS, LCOR, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, SUPT6H, ARNTL, RXRA, BAG3, TPR, HIVEP1, SUDS3, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, NFYC, H3F3A, PER2, CENPF, GFI1B, HIST3H2A, CNOT1, NFIB, NFIC, PKIA, SP3, BCL3, ZNF658, TAF7, EZH2, LIMS1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[NCF1, MAML1, GFI1, ARID4A, RORA, IKZF2, ELK1, YY1, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, ILF3, SFRP1, KARS, IL23A, RFX4, HOXB4, MAX, RLF, SUPT6H, DVL3, SCAP, NLRP3, TFAP2A, DR1, CREBBP, PBX3, ERLIN2, FLI1, SETX, CDK9, NFKBIA, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDKN1C, CIITA, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, NUP62, ZNF485, TBP, KLF13, PEG3, DTX3L, NCOA6, ARNT, SENP2, SAFB, TMEM173, SIRT2, CREB3, GAL, TFDP2, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, ARNTL, SERTAD3, RXRA, TP53INP2, TP53INP1, GPBP1L1, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, GRHL1, USF2, CD4, NFIB, NFIC, CAMK4, TAF7, CAMK1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[NFKBIA, BCL3, TNPO2, KPNB1, ARNTL]
GO:0034620;cellular response to unfolded protein;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;123.17901887317109;6.8867018697843045;0.004122690907765296;0.6753065664753021;[HSPA6]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[FES, CLASP1]
GO:0061684;chaperone-mediated autophagy;6.0;1.0;0.8231203125901445;9.628524252492122;237.71007808667926;8.67846133901236;0.007955942388380075;0.7669372290569613;[LAMP2]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, ABCA12, TM9SF4]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, NCKAP1, CDKN1A, KSR1, DOCK8, RAB27B, RASGRP4, RAB21, RAB43, ABR, DOCK11, RHOT1, COL1A2, RAB20, ALS2, RRAS, RAB18, ELMO1, TAX1BP3, DOCK2, KPNB1, RAB8B]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[FES]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[ALS2, VDAC3, MBP, NPTX1, SNCB, SPG11, KCNK3, NTSR1, PAFAH1B1]
GO:0046621;negative regulation of organ growth;6.0;0.811012628672052;0.7286266269261705;9.360260265897443;146.9345464739773;6.599019797332524;0.0049177670379774545;0.6605944919115335;[WWC3, STK3]
GO:0002374;cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[NLRP3]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[USP36, FEN1, BTG2, CDKN1A, WDR48, DCLRE1C, CIB1, AATF, YY1, POLB, NIPBL, CHAF1A, CASP2, EP300, UPF1, AQR, TIPIN, FBXO18, DTX3L, NCOA6, RAD23A, DDB1, NEIL3, TFDP2, MSH3, TIMELESS, RAD51AP1, NUAK1, POLR2B, POLR2G, USP51, BID, E2F7, E2F8, FANCI, UBE2B, INTS3, GINS4, CNOT10, SETX, CDK9, SMUG1, CNOT6, HIST3H2A, COPS5, CNOT1, UBE2T, BCL3, MNDA, CNOT8]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[PEX16, TRAM1, RPS9, PEX19, NCF1, SSR2, ZDHHC24, RAB8B, RPL19]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[BECN1, TBL2, CPEB4]
GO:0045415;negative regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[BCL3]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[NCKAP1, NCF1, ITGB3, ELMO1, NCKAP1L]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[CSTA, TGM6, THBS1]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[SETX, BECN1, NCF1, ECT2, EZH2]
GO:0071800;podosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;81.13164658075348;7.697632086000634;0.00271540319731635;0.6838982747154925;[NCF1]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[FCER1G, FGG, CD9]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[IGFBP5, THBS1, STK3]
GO:0015891;siderophore transport;6.0;0.7763722522362496;0.7113064387082693;8.935377071932177;25.90782746636903;8.67846133901236;8.671116697684242E-4;0.7669372290569613;[SLC22A17]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB, CDK2AP1, WRNIP1, BAZ1A]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[FCER1G, CALM1]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[NCKAP1, FCER1G, ARPC2, WIPF2, ELMO1, NCKAP1L]
GO:0002220;innate immune response activating cell surface receptor signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;627.0113613116039;5.572381008289503;0.020985505989509944;0.7002128357670632;[CREBBP, FCER1G, EP300, LILRA2]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CREBBP, FCER1G, EP300]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL4R, BCL3, LYST]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, ITGB3, FGG, LAMP2, CD9, RAB27B, CALM1, ALDOA, A2M, THBS1]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[BCL3]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[MAP3K3, OXTR, KSR1, IL5RA, GFRA2, SPTB, RASGRP4, SETX, KARS, PABPN1, PTPRA, NCAM1, CCM2, MBP, CALM1]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[FCER1G, ITGB3, ITGA2, ITGB2, NEDD9, CCM2]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[VPS18, TRIM9, RABGAP1, VPS41, VPS11, TBC1D8, EVI5L, TBC1D22A, VPS16]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, BAG3, TPR, TFEC, HSPA6, SLU7, IER5, THBS1]
GO:0002218;activation of innate immune response;8.0;0.622025257344104;0.686012628672052;8.529911963824013;265.7077617868092;4.551326953967268;0.008892999665543976;0.6077550720842344;[COLEC12, NFKBIA, FGA, ITCH, CREBBP, FCER1G, ITGB2, FGG, EP300, NLRC4, TMEM173, LILRA2]
GO:0060706;cell differentiation involved in embryonic placenta development;4.0;0.8259837884571596;0.6629918942285797;9.089527751759436;40.68519770516384;6.641579411751319;0.0013616969528911006;0.5896506799819907;[SENP2, E2F7, E2F8, STK3]
GO:0098712;L-glutamate import across plasma membrane;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1074.08790550917;7.9853141584524145;0.03594875558103501;0.8564896500084854;[NTSR1]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[NCF1, ATP7A]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[SFRP1, LILRB3]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[NFKBIA, ABCA12]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[HRK, PLAUR, BID, BBC3]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[FES]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[NFKBIA, IRAK1BP1, NKIRAS1, TIFA, BCL3]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[BCL3, UNC13D]
GO:0002227;innate immune response in mucosa;5.0;1.0;0.7902410118609202;9.628524252492122;46.05095502005584;6.832634648514029;0.0015412840213524692;0.639662265535933;[HIST1H2BJ, DEFB1, RNASE3, HIST1H2BC]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G]
GO:0048278;vesicle docking;5.0;0.811012628672052;0.6957473261969462;9.176539128749065;21.38880323109876;5.618190544320798;7.158639954716971E-4;0.5775555375700647;[RAB3B, VPS18, VPS33B, VPS11, RABEPK, STX11, RAB8B]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[IL4R, FCER1G, BCL3]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[CDKN1A, HDAC3, NCF1, ITGB3, CIB1, LRP8, THBS1, STK3, FLCN, DVL3, NCKAP1L, ECT2, MARK2, TBX1, MAP3K3, FGA, FBXO18, KSR1, PDE6H, CCL20, SPHK1, FGG, PLAUR, ZFP91, FLT3LG, SENP2, GFRA2, ERN1, CDK9, CD4, KARS, ALS2, IL23A, JTB, CDK2AP1, CAMK1, ADNP, CALM1, EPHA1, CALM2, ARHGEF5, EZH2]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[FCER1G, CCL20, ITGB2, NCKAP1L]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[CD151, MCTP1, ONECUT2, DOCK8, ITGB3, CIB1, DEFB1, THBS1, ABR, FLCN, NIPBL, RRAS, TBXA2R, ADORA3, TP53INP1, LMNA, NCKAP1L, ATP7A, RFFL, CLASP1, CCR2, BBS2, SEMA6B, MAP3K3, IGFBP5, CCL20, ITGA2, SPHK1, IDH2, PTP4A1, BCR, VIL1, CREB3, SFRP1, KARS, SP1, IL23A, FES, RUFY3, EPHA1]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[NFKBIA, ITGB3]
GO:0017038;protein import;8.0;0.7436939687323844;0.7468469843661922;8.977936686350972;57.348299591639034;4.842599694549778;0.0019193959772133386;0.6226507735831915;[PEX16, PEX19, NUP62, LMNA, LAMP2, NUP153, TNPO2, KPNB1, RAB8B]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[IL4R, FCER1G, NPPA]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[RPS9, RXRA, ITGA2, BCL3, POLR2G, THBS1]
GO:0036294;cellular response to decreased oxygen levels;5.0;0.8653626801206646;0.7229223519212526;9.36615998802463;50.889200100415984;5.023483436574105;0.0017032157300542455;0.5471421884231902;[NPEPPS, SFRP1, TBL2, LMNA, UBQLN1, RORA, ATP7A, KCNK3, SIRT2, CPEB4]
GO:0032495;response to muramyl dipeptide;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.66765988983927;7.004484905440688;0.0019970228791053504;0.6813299963962409;[NFKBIA]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, CAMLG, FES, FAM83A]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[SERPINA3, PDXK, SIGLEC9, CLEC12A, ITGB2, IQGAP2, LILRA2, HK3, PSMD2, PSMB1, LAMP2, NCKAP1L, GUSB, SNAP29, SERPINB1, TMEM30A, FCER1G, HSPA6, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, SERPINB6, RAB18, PTX3, MNDA, DOCK2, ALDOA, KPNB1]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, STK3]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, TRAM1, AHCYL1, NCF1, CLTA, RAB43, NUP62, LAMP2, TMED2, TMED1, ARFIP1, EVI5L, TNPO2, TBC1D22A, RAB8B, VPS18, GSTK1, TMED9, RPS9, SSR2, COG3, TBC1D8, BCR, ACOX2, AGPS, SLU7, KPNB1, ACOT4, RABGAP1, HSD17B4, ZDHHC24, DERL2, VPS26B, TRAK1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, LMNA, VPS11, BID, RPL19, VPS16, PEX16, PEX19, SYVN1, NUP153, RAB27B, ARCN1, NFKBIA, PAN3, SNX17, VPS41, BCL3, RAB18, SEC24C]
GO:0003254;regulation of membrane depolarization;6.0;0.7248374789738407;0.6855390520770648;8.992535485772125;38.60784531422591;6.015873511986907;0.0012921698378621823;0.6307723637598831;[SLMAP, NTSR1]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[SERPINA3, PDXK, SIGLEC9, CLEC12A, ITGB3, ITGB2, IQGAP2, ABCA12, THBS1, STX11, TRIM9, HK3, PSMD2, PSMB1, LAMP2, NCKAP1L, GUSB, A2M, SNAP29, FGA, SERPINB1, TMEM30A, FCER1G, FGG, HSPA6, PLAUR, COMMD3, RAB27B, RNASE3, TMEM173, LILRB3, UNC13D, SERPINB6, COPS5, VPS41, RAB18, CD9, PTX3, MNDA, VAMP4, DOCK2, CALM1, ALDOA, VAMP5, KPNB1, EXOC1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[IL4R, FCER1G, FES, C12orf4, NPPA, UNC13D]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[TFRC, SLC22A17, NEDD8]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, RXRA, ALDH5A1, ATPIF1, ALDOA]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, APOBEC3F, DTX3L, APOBEC3H, DDX41, TMEM173, LYST, UNC13D, ITCH, ILF3, POLR3C, IL23A, NLRP3, SERINC3, EXOC1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, CCL20, SPHK1, RCAN3, DEFB1, NMUR1, CALM1, CALM2, CCR2]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[CREB3, SYVN1, PLAUR, VDAC2, BID]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, SUCNR1, DGKA, DEFB1, IQGAP2, CRHR1, RIC8A, HEBP1, ABR, GNG2, GNAT2, RGS1, TBXA2R, ADORA3, NPPA, OR56B1, ECT2, NTSR1, CCR2, SPHK2, CCL20, SPHK1, TSHR, SFRP1, GAL, GNAQ, GNB2, NMUR1, CALM1, DAGLB, CALM2, ARHGEF5]
GO:1902883;negative regulation of response to oxidative stress;6.0;0.7436939687323844;0.6949672969563367;9.405380701177911;43.093384282952336;5.970411137910149;0.00144229679042247;0.6284474158353811;[MCTP1]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[FCER1G, BCL3, RORA, ATP7A]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB3B, RAB43, RAB20, RAB18, RAB27B, RAB8B]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PDXK, SIGLEC9, CLEC12A, ITGB2, IQGAP2, HK3, PSMD2, PSMB1, LAMP2, NCKAP1L, GUSB, SNAP29, SERPINB1, TMEM30A, FCER1G, HSPA6, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, SERPINB6, RAB18, PTX3, MNDA, DOCK2, ALDOA, KPNB1]
GO:0008277;regulation of G-protein coupled receptor protein signaling pathway;6.0;0.5383299095163034;0.5922852673482962;7.5335785242763205;41.8512380110395;4.8942717050940985;0.0014007232725606145;0.5734135951955668;[PDE6H, RGS1, PDE6B, CALM1, MGLL, RASGRP4]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[HBS1L, RPS9, NDUFA7, COPS5, RPL36AL, MRPS36, MRPS18A, RRBP1, RPL3L, RPL19, CPEB4]
GO:0045064;T-helper 2 cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.67846133901236;0.01585443403193107;0.8762458687964789;[BCL3]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, KARS, LIMS1]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[FCER1G, LNPEP, TAPBP]
GO:2001259;positive regulation of cation channel activity;9.0;0.7043150770688792;0.7483981637147287;9.126432308694886;526.0857391442704;5.75172193694532;0.017607616242732247;0.6903839525180965;[GAL, NPPA, CALM1, CALM2, NTSR1]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[BCR, ABR, FCER1G, ITGA2, SIRPG, PTX3, NCKAP1L, DOCK2, C2]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, SYS1, FCER1G, SLMAP, TMED2, ABCA12, VAMP5, RAB8B]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[HIST1H2BO, HIST1H2BJ, RNF38, CCNF, NEDD8, DTX2, NLRC4, ANAPC11, UBE2L3, VCPIP1, TRIM9, NPEPPS, HERC1, TRIM24, TRIM69, RFFL, SKP2, C18orf25, UBE2I, UBE2B, FBXO18, KLHL25, DTX3L, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, DDB1, ITCH, KCTD10, UBE2T, TSPAN17, FBXL3, ANAPC5, HIST1H2BC]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[VIL1, MKLN1, CFDP1, EPB41, FES, WIPF2, LST1, ITGB2, ALDOA]
GO:0046716;muscle cell cellular homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.94563669038233;6.781341354126479;0.0010691917108206317;0.6370391240755715;[LAMP2, ALDOA]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, TBC1D8, TAX1BP3, EVI5L, ECT2, EPHA1, TBC1D22A]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[PDE6H, NCF1, NUP62, PLAUR]
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;12.0;0.9326813400603323;0.9144609826203107;9.611429819132821;2972.107935112762;7.292166977892469;0.09947377786474029;0.8210420709600095;[NCF1]
GO:0046835;carbohydrate phosphorylation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;67.30508528847182;6.518977089658987;0.002252640633960971;0.6565011041187423;[GNPTG, HK3]
GO:0097151;positive regulation of inhibitory postsynaptic potential;8.0;1.0;0.875;9.628524252492122;396.3633467743015;7.8311634786251565;0.013265924512682948;0.7754860644832351;[NTSR1]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[NFKBIA]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[COL1A2, ATP7A, CPEB4]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[COLEC12, NFKBIA, TMEM173]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[NCKAP1, CUEDC2, SIGLEC9, TFRC, WIPF2, GFI1, C12orf4, ITGB2, NPPA, EP300, CCR2, IFNAR2, FGA, IL4R, FCER1G, PVRIG, FGG, TMEM173, UNC13D, BCR, KARS, CD8B, IL23A, ELMO1, ANKRD17, COLEC12, NLRC4, LILRA2, SUPT6H, C2, ABR, UBQLN1, SLAMF7, NLRP3, NCKAP1L, A2M, CREBBP, AMBP, BTN2A1, PILRA, NFKBIA, ITCH, CD4, COL1A2, ARPC2, POLR3C, FES, MNDA, CALM1, C1QC]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[NFKBIA, SFRP1, KLF13, CIB1, LILRB3, C1QC]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[CD4, IL23A, FES, ARNT, NCKAP1L]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[NCKAP1, NCF1, ITGB3, NEDD9, RASGRP4, TIAL1, SGPL1, POLR2B, POLR2G, NCKAP1L, ATP6V1F, FAM83A, CAMLG, PILRA, GFRA2, SIRT2, SETX, BCR, VIL1, CD4, SLC9A6, ARPC2, CD8B, PTPRA, FES, ELMO1, EPHA1]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[HSPA6]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[NCKAP1, OXTR, NCF1, MAML1, WIPF2, IL5RA, CIB1, PKD2L1, RORA, TIAL1, GNAT2, ADORA3, NPPA, EP300, TLE4, IFNAR2, SEMA6B, IL4R, CSNK2A1, FLT3LG, RUNX2, BCR, SFRP1, KARS, SLC9A6, CD8B, IL23A, ELMO1, PSME2, EPHA1, CD151, DIABLO, DTX2, APCDD1, CRHR1, RASGRP4, SGPL1, BAG3, TSPAN7, TSPAN4, DVL3, NCKAP1L, TSPAN2, MARK2, ATP6V1F, FAM83A, BBS2, CREBBP, UBE2B, BTN2A1, IFT122, PILRA, SETX, VIL1, NFKBIA, COL1A2, ARPC2, PTPRA, FES, GNAQ, SDC1, CALM1, CPEB4, CIITA, CDKN1A, SIGLEC9, ITGB3, ITGB2, NUP62, CASP2, CCR2, DACT1, FCER1G, CAMLG, ITGA2, ROM1, PLAUR, PDCD1LG2, SENP2, GFRA2, YWHAZ, SIRT2, DDB1, TAX1BP3, LCP1, DAGLB, NOTCH2NL, NEDD9, LILRA2, LRP8, AKAP2, GNG2, POLR2B, MKNK2, IL21R, POLR2G, NCAM1, BID, MAP3K3, CCL20, G0S2, LILRB3, TSHR, ITCH, CD4, TSPAN17, CD9, CCM2, MNDA, LIMS1]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[IL4R, NLRP3]
GO:0044546;NLRP3 inflammasome complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;9.777073627680469;0.0014899461700306506;0.8231203125901445;[NLRP3]
GO:0060215;primitive hemopoiesis;7.0;1.0;0.8509193652572005;9.628524252492122;36.11381869205014;8.67846133901236;0.0012086970112961952;0.7947362817240173;[STK3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, SFRP1, HDAC1, DVL3, DACT1, STK3]
GO:0002268;follicular dendritic cell differentiation;4.0;1.0;0.75;9.628524252492122;31.7169698415401;9.083926447120524;0.0010615384371766854;0.714552420951524;[BCL3]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[BCR, UPF1, ABCC2, PABPN1, NLRP7, TBXA2R, CCL20, GFI1, NLRP3, PDCD1LG2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, COLEC12, HIST1H2BJ, NCF1, DEFB1, NLRC4, LILRA2, LYST, C2, PRDX1, SLAMF7, NLRP3, FGA, APOBEC3F, FCER1G, DTX3L, APOBEC3H, WRNIP1, RNASE3, TMEM173, SIRT2, ITCH, POLR3C, IL23A, FES, TRIM14, PTX3, SERINC3, CD244, C1QC, HIST1H2BC]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[VIL1, VASP, NCKAP1, ARPC2, WIPF2, NCKAP1L, IQGAP2]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[NLRP3]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[NFKBIA, MAP3K3]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[RAB43, RAB20, CCL20, VPS26B]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[MAP3K3, PDE6H, CIB1, THBS1, STK3, ERN1, KARS, ALS2, DVL3, CAMK1, CALM1, CALM2, ARHGEF5, EZH2]
GO:0045082;positive regulation of interleukin-10 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;9.083926447120524;0.027942676825076673;0.839552420951524;[BCL3]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[ERRFI1, BCL3]
GO:0045806;negative regulation of endocytosis;7.0;0.7192862368539868;0.710562483684194;9.057979394024509;124.57926064357885;5.8650506222523235;0.004169555739685066;0.6508583268319309;[ATXN2, MCTP1]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[BECN1, NCF1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[FES, NUP62, CKAP5]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[NLRP12, NLRP7, NLRP3]
GO:0046579;positive regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;287.86983276338884;5.905872616772578;0.009634744236561129;0.6982672254532021;[ALS2, RASGRP4]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[CDKN1A, BCL3, EP300]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[NLRC4]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[IL23A, BCL3, CD244, CCR2]
GO:0050713;negative regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;7.379178354882098;0.033445798446087804;0.8098004765652196;[NLRP7, NLRP3]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN5, HLA-DMA, FCER1G, DCTN4, CLTA, CTSE, SEC24C, DYNLL2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[HIST1H2BJ, NLRP3, DEFB1, RNASE3, HIST1H2BC]
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;424.7653704329427;6.943860283624253;0.014216514684375884;0.7703503496879909;[SFRP1, THBS1, STK3]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[NFKBIA, NLRP12, SUCNR1, FCER1G, KARS, IL23A, ITGA2, NPPA, CCR2]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[SLC36A1, SLC25A3, COX4I1, ATP5I, COX5B, ATP5O, COX6A1, CLCN3, ATP5L, COX7A2L, SLC9A6, NDUFS7, CYC1, ATP6V1F]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, VASP, PDCD6IP, KCND1, FCER1G, ATPIF1, PKD2L1, NLRC4, CLYBL, MARCKS, SPAST, RXRA, ALDH5A1, KCTD10, ECT2, ALDOA, BID]
GO:0006336;DNA replication-independent nucleosome assembly;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;163.41517932017535;6.088194173566533;0.005469358987733092;0.6863505331661754;[H3F3A, UBN1, OIP5, CENPP]
GO:0009966;regulation of signal transduction;5.0;0.3290196849396939;0.45475085433076723;5.351858133476067;37.58855813399747;1.7469895334129066;0.0012580552132388425;0.37958213784297784;[ERRFI1, NCF1, MAML1, GFI1, CIB1, RORA, RGS1, NPPA, TRIM24, WWC3, EP300, SKP2, TLE4, IFNAR2, CSNK2A1, FBXO18, IGFBP5, FLT3LG, RUNX2, ERN1, BCR, DEPDC1B, SFRP1, KARS, SLC9A6, IL23A, RFX4, VDAC2, PKP4, EPHA1, ANKRD17, CLEC16A, APCDD1, GLG1, RASGRP4, STK3, ABR, ARHGAP21, NUAK1, RHOT1, RRAS, RDH11, PRDX1, STK38, DVL3, NLRP3, ECT2, A2M, NTSR1, CREBBP, UBE2I, UBE2B, AMBP, STARD10, IFT122, ARHGAP25, NFKBIA, COPS5, CNOT1, GNAQ, RCAN3, BCL3, SERINC3, CALM1, CALM2, EZH2, CDKN1C, HRK, ONECUT2, ITGB3, OTUD7B, BBC3, DUSP14, FLCN, AKAP11, LBH, NUP62, CASP2, DACT1, FGA, TBP, KSR1, PVRIG, BUD31, SPHK1, ATPIF1, RHBDF2, FGG, PLAUR, ZFP91, ARNT, ZDHHC13, SENP2, GFRA2, YWHAZ, CREB3, GAL, ALS2, TFDP2, TAX1BP3, CHMP6, ARHGEF5, MGLL, PAFAH1B1, BECN1, HDAC3, HIST1H2BJ, HDAC1, WBP2, NLRC4, LILRA2, THBS1, ARNTL, SNX25, TP53INP1, LMNA, UBQLN1, PDE6B, RFFL, BID, TBX1, CMTM7, MAP3K3, PDE6H, CCL20, SYVN1, G0S2, FBXL15, ITCH, CD4, NLRP12, TSPAN17, TAF7, KCNK3, LIMS1]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HIST1H2BO, CHAF1A, HIST1H2BJ, H3F3A, UBN1, OIP5, TSPYL6, CENPP, MCM2, HIST1H2BC]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[HIST1H2BJ, DEFB1, RNASE3, HIST1H2BC]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[FCER1G]
GO:0001678;cellular glucose homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;49.180086311476984;5.514393750639154;0.0016460132296410052;0.6329257181104212;[ERN1, HK3]
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;7.8311634786251565;0.01635334542256394;0.8630410292508717;[NFKBIA]
GO:0031629;synaptic vesicle fusion to presynaptic active zone membrane;8.0;1.0;0.875;9.628524252492122;97.90557556088102;7.212124270218933;0.0032768115047252227;0.7438283705770736;[SNAP29, STX11]
GO:0030099;myeloid cell differentiation;4.0;0.6913464685778243;0.5956732342889122;8.146919711567906;21.066225782797595;4.720827822332161;7.050676185779127E-4;0.49142335437501145;[SNRK, FCER1G, TFRC, NCOA6, CAMK4, SP3, ATPIF1, EP300, CIB1, RASGRP4]
GO:2000766;negative regulation of cytoplasmic translation;9.0;0.7980440201809971;0.7952626352707877;9.4949928598676;1334.6807050748262;7.57984905034425;0.04467056206420413;0.7838744581139225;[CPEB4]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[FCER1G, SYNJ1, TFRC, ITGB2, CD9]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[NTSR1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[COLEC12, ERRFI1, ABCC2, IGFBP5, ITGA2, ITPR2, RORA, TMEM173, LRP8, ELK1, SIRT2, UBE2L3, NFKBIA, SFRP1, GNG2, XRN1, EZH2]
GO:0015711;organic anion transport;6.0;0.43219213062620165;0.5392163779032453;6.26616670414623;28.19857810171702;3.758480413184235;9.437810319917961E-4;0.5153291757075998;[SLC36A1, SLC23A2, PLA2G12A, TMEM30A, ABCC2, PITPNB, ABCC5, STARD10, ABCA12, RXRA, CPT2, SLC22A17, SLC16A6, SLC25A20, SERINC3, NTSR1]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[FCER1G, ITGB2, CD9]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[COLEC12, VASP, RRM1, PDCD6IP, CPSF6, KCND1, FCER1G, ATPIF1, PKD2L1, NLRC4, HSD17B8, CLYBL, MARCKS, SPAST, RXRA, ALDH5A1, COL1A2, KCTD10, NUP62, NLRP3, ECT2, ALDOA, BID]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[MARCKS, NEDD9, LCP1]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[CDKN1A, WDR48, NCF1, ZFAND2A, ITGB3, CIB1, BBC3, UBE2L3, FLCN, NIPBL, SKP2, DACT1, FGA, RPS9, FBXO18, KSR1, ITGA2, SPHK1, ATPIF1, FGG, PLAUR, ZFP91, ARNT, FLT3LG, RAD23A, SENP2, GFRA2, SIRT2, ERN1, KARS, ALS2, IL23A, MTF2, JTB, PSME2, ADNP, EPHA1, ARHGEF5, HDAC3, CDCA2, WBP2, DIABLO, NLRC4, LRP8, THBS1, ARNTL, STK3, RXRA, PPP1R7, VPS11, UBQLN1, DVL3, NLRP3, POLR2G, MBP, NCKAP1L, ECT2, BID, MARK2, TBX1, FANCI, MAP3K3, UBE2I, PDE6H, CCL20, EDEM1, CDK9, NFKBIA, CD4, NLRP12, BCL3, CDK2AP1, CAMK1, CALM1, CALM2, EZH2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BECN1, BTG2, CDKN1A, LST1, SIRPG, CIB1, COMT, THBS1, STK3, FLCN, ADORA3, RPS6KA2, FNTB, NUP62, TP53INP1, LMNA, TRIM24, RBM5, E2F7, TFAP2A, KLF13, IGFBP5, ATPIF1, IDH2, IFT122, EMP3, PDCD1LG2, SIRT2, PER2, ITCH, SFRP1, GAL, KARS, FAP, NFIB, CD9, TAX1BP3, MNDA, CNOT8]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, HDAC1, ITGB3, FOXG1, SIRPG, CCNF, DERL2, CIB1, CRIP2, THBS1, TIAL1, PPP1CC, LBH, FNTB, SOX8, NCKAP1L, ATP7A, SKP2, CCR2, TBX1, MAP3K3, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, TSHR, RUNX2, ERN1, CNOT6, CD4, SFRP1, SP1, IL23A, CNOT8, EPHA1, CCNJL]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[NDUFA7, NDUFB7, NDUFB10, NCF1, TXNRD1, COX4I1, NDUFA10, ETFB, COX5B, COX6A1, COX7A2L, ALDH5A1, NDUFS7, UQCRQ, NDUFS6, IDH3B, CYC1, BID]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CIITA, ONECUT2, ELL, MAML1, GFI1, ARID4A, RORA, DDX41, HOXC13, AATF, IKZF2, ELK1, YY1, FLCN, NIPBL, DPF2, EP300, SOX8, IER5, ZNF564, IER2, ZNF485, KLF13, PEG3, NCOA6, ARNT, FLT3LG, SENP2, SAFB, TMEM173, MED6, RUNX2, SIRT2, CREB3, GAL, TFDP2, IL23A, RFX4, MTF2, TFEC, HOXB4, HDAC3, ZNF350, HDAC1, WBP2, MAX, RLF, SUPT6H, ARNTL, RXRA, SCAP, NLRP3, E2F7, E2F8, TBX1, TFAP2A, ZNF462, DR1, CREBBP, NFYC, ATAD2, PBX3, ERLIN2, GRHL1, USF2, FLI1, SETX, CDK9, NFKBIA, TFCP2, COPS5, SP1, NFIB, NFIC, SP3, MAFF, BCL3, TAF7, CAMK1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, ADNP, SNCB, CPEB4]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[MTPN, BTG2, EIF4E3, CASC3, THBS1, EIF4ENIF1, ATXN2, RXRA, TPR, MKNK2, POLR2G, UPF1, RPS9, KLHL25, IGFBP5, ITGA2, CNOT10, PER2, CNOT6, ILF3, XRN1, CNOT1, BCL3, EIF4E2, CNOT8, CPEB4]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[MNDA]
GO:0015808;L-alanine transport;11.0;0.8933024483968273;0.8790801765280758;9.567899630675686;156.4478742426539;7.8311634786251565;0.005236169556955925;0.8329150168128974;[SLC36A1]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ERN1, MAP3K3, KARS, PDE6H, ITGB3, ZFP91, NCKAP1L, ADNP, ECT2, THBS1, MARK2, STK3]
GO:0034329;cell junction assembly;4.0;0.7140352122741334;0.6070176061370667;8.529911963824013;35.00514165935835;4.7018998124466425;0.0011715905887565515;0.49045537506922354;[VASP, UGT8, FLCN, PDCD6IP, CD151, ITGA2, CD9, PKP4, ECT2, LIMS1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[NCKAP1L, MNDA]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, WDR48, USP32, USP12, OTUD7B, NEDD8, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, RHOT1, PSMD2, PSMB1, NLRP3, USP51, SKP2, USP46, RAD23A, NFKBIA, COPS5, PSMA1, PSME2]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[RHOT1, MCTP1]
GO:0061740;protein targeting to lysosome involved in chaperone-mediated autophagy;12.0;1.0;0.9481203125901445;9.628524252492122;450.1958901409887;8.67846133901236;0.01506765129302233;0.8919372290569614;[LAMP2]
GO:0014054;positive regulation of gamma-aminobutyric acid secretion;9.0;1.0;0.896240625180289;9.628524252492122;403.17799630906705;8.67846133901236;0.013494004699825146;0.8400575416471059;[NTSR1]
GO:0051280;negative regulation of release of sequestered calcium ion into cytosol;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;673.651588659943;7.212124270218933;0.02254651242537939;0.7840693824379941;[CALM1, CALM2, NTSR1]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[BECN1, GABARAPL1, SFRP1, CDKN1A, TBL2, MAX, LAMP2, CLEC16A, COMT, FADS1, CPEB4]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CALM1, CALM2, NTSR1]
GO:0061621;canonical glycolysis;15.0;1.0;0.9883613244510648;9.628524252492122;17318.20443184688;6.558197802812269;0.5796247169618144;0.8237478650742711;[HK3, TPI1, BPGM, ALDOA]
GO:0097352;autophagosome maturation;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.599019797332524;0.0012734203321220245;0.6277151911823093;[GABARAPL1, LAMP2, UBQLN1, SNAP29, VPS16]
GO:0051156;glucose 6-phosphate metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;72.82688802824934;6.686031174322154;0.0024374504023614934;0.6321649570480018;[RPIA, HK3, G6PC3]
GO:0015816;glycine transport;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;184.47124825534323;7.474488534686424;0.006174086665761407;0.7974867031240476;[SLC36A1]
GO:0071545;inositol phosphate catabolic process;7.0;0.8653626801206646;0.7836007053175329;9.533214072687796;269.2464749618552;7.004484905440688;0.009011437210877672;0.7091290490632969;[SYNJ1, NUDT3, NTSR1]
GO:0019731;antibacterial humoral response;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;115.72816977122699;6.221725566191056;0.0038733176936520722;0.6690987000520388;[FGA, HIST1H2BJ, DEFB1, RNASE3, HIST1H2BC]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[FGA, HIST1H2BJ, BCL3, DEFB1, RNASE3, HIST1H2BC]
GO:0034315;regulation of Arp2/3 complex-mediated actin nucleation;12.0;0.8933024483968273;0.8947715367885583;9.548481544818586;156.01683371715592;7.004484905440688;0.005221743018478795;0.8063299963962409;[NCKAP1, ARFIP1]
GO:0035524;proline transmembrane transport;11.0;0.8653626801206646;0.8651102923899945;9.584072489921288;330.9290371701472;7.9853141584524145;0.011075897057287277;0.8407982897480031;[SLC36A1]
GO:0014049;positive regulation of glutamate secretion;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;414.8970628992697;7.474488534686424;0.013886231312124032;0.7784863164434164;[NTSR1]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[GNL3L, DTX3L, EPB41, EP300, TMEM173, DACT1, STK3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, WBP2, MAX, INTS10, ARID4A, HOXC13, ELK1, SUPT6H, GTF2E2, ARNTL, POLR2B, TRIM24, ZNF768, HIVEP1, EP300, POLR2G, IER2, GTF2I, TFAP2A, POLR2J3, TBP, KLF13, NFYC, INTS3, PBX3, ARNT, GRHL1, USF2, FLI1, CDK9, CREB3, GFI1B, TFCP2, COPS5, TFDP2, SP1, NFIB, NFIC, RFX4, TFEC, MAFF, INTS4, LCOR, TAF7]
GO:0038195;urokinase plasminogen activator signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;9.083926447120524;8.87013979980389E-4;0.7876727335416686;[PLAUR]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[NIPBL, ITGA2, PLAUR, SIRT2]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[FGA, FGG, PLAUR]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[MAP3K3, OXTR, KSR1, IL5RA, GFRA2, SPTB, RASGRP4, STK3, SETX, KARS, PABPN1, PTPRA, NCAM1, CCM2, MBP, CALM1]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[PER2, NFKBIA, ZNF462, SUMO3]
GO:0002315;marginal zone B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;7.57984905034425;0.005013908926038414;0.7838744581139225;[DOCK11, BCL3]
GO:0048168;regulation of neuronal synaptic plasticity;8.0;0.7980440201809971;0.7740220100904985;9.223059144383958;41.65758488823441;5.8067817141283475;0.0013942418768168238;0.6719590869034888;[MCTP1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[FCER1G, IL23A, THBS1, CCR2]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[TMEM30A, TRAK1, LRP8, RAB21, SETX, FES, RUFY3, DVL3, CAMK1, ADNP, SCARF1, MARK2, PAFAH1B1, EZH2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[NLRP12, DIABLO, NLRP3, NLRC4, BID, BBC3]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[CD151, MCTP1, FCER1G, ITGA2, SIRPG, C2, RAB21, BCR, RUFY1, ABR, ATXN2, RAB20, SYNJ1, SNX17, PTX3, NCKAP1L, DOCK2]
GO:0035235;ionotropic glutamate receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.310070521373587;27.195621953761602;6.558197802812269;9.102129923216596E-4;0.6863059058804069;[CPEB4]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[NLRP3]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LILRA2]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[NFKBIA, ITCH, NLRP12, ADORA3, GFI1, NLRP3]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[NFKBIA, ITGB2]
GO:0090385;phagosome-lysosome fusion;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;65.8060249050737;7.697632086000634;0.0022024684319953925;0.7445766281117727;[RAB20, SPG11]
GO:0090383;phagosome acidification;12.0;0.9326813400603323;0.9144609826203107;9.57973408832269;182.53781204849716;8.390779266560578;0.006109376295897887;0.8772251544931927;[RAB20]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ANKRD17, FGA, FCER1G, HIST1H2BJ, CCL20, DEFB1, RNASE3, NLRC4, LYST, CD4, IL23A, BCL3, NLRP3, HIST1H2BC]
GO:0046426;negative regulation of JAK-STAT cascade;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;286.97803335492995;5.845247994956144;0.009604896512927369;0.6951668794741764;[BCL3]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[MAP3K3, KARS, NCF1]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[CSTA]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[GAL, NPPA, NMUR1, NTSR1]
GO:0030330;DNA damage response, signal transduction by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.4949928598676;85.94894796857642;5.407625775213448;0.0028766339394770053;0.627465598881932;[CNOT6, BTG2, CDKN1A, TFDP2, CNOT1, BCL3, CASP2, EP300, CNOT10, CNOT8, E2F7, E2F8]
GO:2000321;positive regulation of T-helper 17 cell differentiation;13.0;0.9326813400603323;0.9288956347978027;9.611994950540911;2604.3016792955605;7.697632086000634;0.08716363348667819;0.8562122276222088;[IL23A, NLRP3]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[NFKBIA]
GO:0016045;detection of bacterium;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;95.72483819449377;7.697632086000634;0.0032038241876084527;0.7167775754447168;[NLRC4]
GO:0010745;negative regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;114.21841186311113;7.212124270218933;0.0038227874551613377;0.6919486831672181;[NFKBIA, ITGB3]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[FCER1G, MBP]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[MCTP1, IGFBP5, IDH2, THBS1, BCR, ABR, FLCN, SFRP1, RRAS, TBXA2R, ADORA3, TP53INP1, EPHA1, CLASP1]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[NLRP3]
GO:0051457;maintenance of protein location in nucleus;7.0;0.811012628672052;0.7564256795932265;9.292052015870908;48.00389740763819;6.686031174322154;0.0016066472455308106;0.692843310444282;[BCL3]
GO:0031665;negative regulation of lipopolysaccharide-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;344.71221365858594;7.212124270218933;0.011537207570301822;0.7197477358342742;[LILRA2]
GO:0032754;positive regulation of interleukin-5 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[NLRP3]
GO:0090238;positive regulation of arachidonic acid secretion;10.0;1.0;0.9152410118609203;9.628524252492122;484.2610177665766;8.16763571524637;0.01620778045802629;0.8329342821725234;[NTSR1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[IFNAR2, BECN1, APOBEC3F, DTX3L, APOBEC3H, DDX41, TMEM173, LYST, UNC13D, ITCH, ILF3, POLR3C, IL23A, BCL3, NLRP3, SERINC3, EXOC1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[NFKBIA, RPL19, EZH2]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, SERPINB1, CSTA, ITIH2, CSNK2A1, AMBP, SERPINA10, PLAUR, NLRC4, THBS1, SERPINB6, VIL1, NLRP7, RFFL, A2M]
GO:0070427;nucleotide-binding oligomerization domain containing 1 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;9.083926447120524;0.01635334542256394;0.9271073857191605;[NFKBIA]
GO:0050708;regulation of protein secretion;7.0;0.544374901031353;0.623106815772877;7.862740269667327;96.15283043706451;3.7392027077583316;0.003218148702799284;0.5421423656226702;[FGA, IL4R, RHBDF2, IDH2, FGG, ITPR2, ARNTL, PER2, NLRP12, SFRP1, KARS, NLRP7, NLRP3, MBP, ARFIP1, CD244, EXOC1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[NAB1, GFI1, ARID4A, IKZF2, ELK1, UBE2L3, YY1, SAP130, ZXDC, DPF2, TRIM24, EP300, ZNF326, SOX8, ZNF688, IER5, ZNF564, IER2, GTF2I, TLE4, ZNF441, CSNK2A1, ZNF282, SND1, ERN1, EID1, ILF3, ZNF93, RFX4, HOXB4, TIMELESS, ADNP, ZNF276, ZNF550, ZNF394, MAX, FOXG1, ZNF20, RLF, SUPT6H, GTF2E2, ZNF549, HIVEP1, ZNF548, NLRP3, SUDS3, TRAPPC2, TFAP2A, DR1, INTS3, PBX3, CNOT10, FLI1, SOX30, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, ZNF30, MAFF, BCL3, ZNF658, INTS4, CNOT8, TMEM18, ZNF532, ZNF410, EZH2, PHF3, SETD5, CIITA, BTG2, ONECUT2, ELL, INTS10, ATF7IP2, HOXC13, CHD1, NIPBL, ZMYM2, LBH, SCML1, NUP62, ZNF768, ZNF525, LRRFIP1, ZNF485, TSC22D4, TBP, KLF13, BUD31, COMMD3, ARNT, BAZ1A, SAFB, ZFX, MED29, SIRT2, CREB3, ZNF519, TFDP2, TFEC, LCOR, VGLL4, ZNF630, HDAC3, ZNF350, HDAC1, WBP2, ZNF69, ARNTL, SERTAD3, POLR2B, TP53INP2, TP53INP1, POLR2G, GPBP1L1, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, ZNF462, NFYC, ATAD2, GRHL1, USF2, PER2, GFI1B, POLR3C, NFIB, NFIC, TAF7, MNDA]
GO:0031098;stress-activated protein kinase signaling cascade;6.0;0.7980440201809971;0.722142322680643;9.193206181234276;55.4262366053078;5.142344639450834;0.0018550662588052154;0.5861000565951415;[MAP3K3, CCM2, STK3]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[MAML1, GFI1, IKZF2, ELK1, UBE2L3, TIAL1, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, IER5, IER2, CSNK2A1, ZNF282, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, KARS, IL23A, RFX4, HOXB4, TRIM14, ZNF276, ZNF394, FOXG1, ZNF20, HIVEP1, SCAP, CREBBP, H3F3A, PBX3, ERLIN2, FLI1, SOX30, SETX, GOLGB1, PKIA, ZNF30, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, ELL, ATF7IP2, OTUD7B, HOXC13, AATF, NIPBL, ZMYM2, SCML1, ZNF485, TSC22D4, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, ZFX, MED29, SIRT2, TOX4, GAL, MTF2, TFEC, VGLL4, ARHGEF5, ZNF350, NEDD8, TRAK1, ZNF69, ARNTL, SERTAD3, RXRA, UBN1, GPBP1L1, SCAND1, ZNF462, NFYC, ATAD2, GRHL1, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, CAMK4, CAMK1, LIMS1, NCF1, NAB1, GMNN, ARID4A, CIB1, RORA, YY1, ADORA3, WWC3, EP300, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, ERN1, ILF3, ZNF93, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, SUDS3, TRAPPC2, TFAP2A, DR1, UBE2I, CNOT10, CDK9, NFKBIA, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, CNOT8, ZNF532, ZNF410, USP36, CIITA, ONECUT2, ITGB2, DDX41, CHD1, FLCN, LBH, NUP62, GATAD1, ZNF768, ZNF525, LRRFIP1, DACT1, TBP, KLF13, PEG3, DTX3L, BUD31, ZFP91, ARNT, SENP2, SAFB, CREB3, ZNF519, TFDP2, LCOR, ZNF630, MTPN, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TP53INP2, TP53INP1, ASCC3, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, USF2, CD4, POLR3C, TAF7, MNDA]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[GNAQ, NMUR1, RASGRP4]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[NCKAP1, FCER1G, ARPC2, WIPF2, ELMO1, NCKAP1L]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[CD244, NTSR1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[MAML1, GFI1, ARID4A, RORA, IKZF2, ELK1, YY1, TIAL1, SAP130, ZXDC, DPF2, WWC3, EP300, SOX8, IER5, ZNF564, IER2, GTF2I, TLE4, ZNF441, ZNF282, SSU72, FLT3LG, MED6, RUNX2, EID1, THAP6, SFRP1, ZNF93, IL23A, RFX4, HOXB4, TIMELESS, ADNP, ZNF276, ZNF550, ZNF394, MAX, FOXG1, ZNF20, RLF, SUPT6H, BAG3, TPR, ZNF549, HIVEP1, ZNF548, SCAP, NLRP3, SUDS3, TFAP2A, DR1, CREBBP, UBE2I, PBX3, ERLIN2, FLI1, SOX30, SETX, CDK9, NFKBIA, TFCP2, COPS5, CNOT1, SP1, PKIA, SP3, ZNF30, MAFF, BCL3, ZNF658, ZNF532, ZNF410, EZH2, CIITA, AHCTF1, BTG2, CDKN1A, ONECUT2, ELL, OTUD7B, DDX41, HOXC13, AATF, CHD1, FLCN, NIPBL, ZMYM2, GATAD1, ZNF768, ZNF525, LRRFIP1, DACT1, ZNF485, TSC22D4, TBP, KLF13, PEG3, NCOA6, BUD31, ZFP91, ARNT, SENP2, SAFB, TMEM173, ZFX, SIRT2, TOX4, CREB3, GAL, ZNF519, TFDP2, MTF2, TFEC, LCOR, HDAC3, ZNF350, HDAC1, WBP2, NEDD8, TRAK1, LRP8, ZNF69, ARNTL, RXRA, UBN1, E2F7, ZNF189, E2F8, IRX1, TBX1, ZNF462, NFYC, ATAD2, FBXL15, GRHL1, USF2, PER2, GFI1B, NFIB, NFIC, TAF7, CAMK1]
GO:0002674;negative regulation of acute inflammatory response;8.0;0.7369933605727446;0.7434966802863723;9.132087366178231;164.84175655116067;7.292166977892469;0.005517105243818016;0.747921758369865;[NLRP3]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[FCER1G, TFRC]
GO:0032736;positive regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.069023426578259;0.002183412136085803;0.6846304993685643;[NLRP3]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[BBS2, SPAG16, SPAST, UBE2B, FES, CLASP1, IQCG]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[ERN1, NCF1, DVL3, ARHGEF5, STK3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[BTG2, CDKN1A, DOCK8, CIB1, AATF, NUP62, CASP2, SOX8, TSC22D4, FGA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, BECN1, HDAC3, HDAC1, NLRC4, THBS1, BAG3, LMNA, NCKAP1L, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, UBE2B, SYVN1, SETX, VIL1, NFKBIA, ITCH, SON, COPS5, BCL3, PDCD1, MAD2L1, CPEB4]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, DIABLO, NLRC4, THBS1, BBC3, STK3, ABR, FLCN, RPS6KA2, TP53INP1, CASP2, NLRP3, SUDS3, ECT2, BID, RBM5, NTSR1, TFAP2A, FBXO18, ATPIF1, PLAUR, G0S2, YWHAZ, SIRT2, NLRP12, SFRP1, GAL, TFDP2, FAP, PTRH2, MNDA, PDCD1, SERINC3, ARHGEF5]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[NLRC4]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[STK3]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[FCER1G, IL23A, BCL3]
GO:0070779;D-aspartate import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;425.4525215124219;8.390779266560578;0.014239513012610231;0.8615337942327104;[NTSR1]
GO:0050701;interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.523163736834295;137.06961104194002;7.474488534686424;0.004587596526932657;0.7974867031240476;[NLRP3, NLRC4]
GO:0070417;cellular response to cold;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;50.719091001651144;7.697632086000634;0.0016975223316068359;0.6838982747154925;[NFKBIA]
